Scott, Frank I.
Lichtenstein, Gary R.
Article History
First Online: 1 March 2018
Compliance with Ethical Standards
:
: Frank I. Scott has received a grant from Takeda Pharmaceuticals and has received personal fees from Janssen Pharmaceuticals and Merck Pharmaceuticals.Gary R. Lichtenstein has received personal fees from Abbvie, Actavis, Alaven, Ironwood, Gilead, Hospira, Luitpold/American Regent, Merck, McMahon Publishing, Prometheus Laboratories, Romark, Salix Pharmaceuticals/Valent, Shire Pharmaceuticals, SLACK, Inc., Springer Science and Business Media, UCB, and Up-To-Date. Dr. Lichtenstein has also received grants and personal fees from Celgene, Janssen Ortho Biotech, Pfizer Pharmaceuticals, and Takeda, and honorarium payments from Clinical Advances in Gastroenterology and Gastroenterology and Hepatology (Gastro-Hep Communications).
: This article does not contain any studies with human or animal subjects performed by any of the authors.